글로벌 청색증 심장병 시장 – 2029년까지의 산업 동향 및 예측

청색증 심장병 시장 분석 및 규모

청색증 심장병 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 청색증 심장병 시장의 성장은 청색증 심장병의 증가하는 사례와 의료비 지출 증가로 인해 강화되었습니다. 지속적인 약물 발견과 정부 및 비정부 조직 이니셔티브를 포함하는 의료 발전이 시장 성장을 촉진하는 것입니다. COVID-19도 시장 성장에 큰 영향을 미쳤습니다.

Data Bridge Market Research는 2022-2029년 예측 기간 동안 글로벌 청색증 심장병 시장의 성장률을 분석합니다. 글로벌 청색증 심장병 시장의 예상 CAGR은 언급된 예측 기간 동안 약 9%인 경향이 있습니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

시장 정의

청색증 심장병은 출생 시 나타나는 다양한 심장 결함 그룹에 부여된 포괄적인 용어입니다. 일반적으로 혈액 내 산소량이 낮고 청색증은 피부와 점막이 푸르스름한 색상으로 정의되는 것이 특징입니다. 이는 의료 분야에 매우 중요하므로 예측 기간 동안 크게 증가할 것으로 예상됩니다.

청색증 심장병 시장 범위 및 세분화

Global Cyanotic Heart Disease Market Dynamics

Drivers

• Increased Incidence of Cyanotic Heart Disease

According to the Lancet medical journal reports, approximately 0.22 million individuals and newborns died globally in 2010. Cyanotic heart disease was earlier associated with premature births, but actually the association has no direct relation with all forms of CHD. Its prevalence is increasing and its treatment is of great importance to the healthcare sector.

• Rising Demand for Oral Drugs

Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.

Opportunities

• Rising Demand For Diagnostic Tests

Ultrasound sonography performed before birth is really useful in detecting this disease. However, some heart defects may go undetected for life. Genetic testing/screening is compulsory in cases where the doctor suspects a genetic cause for the concerned disease. This creates more opportunity in the market.

Restraints/Challenges

• Lack of Skilled Professionals

Lack of trained professionals who are unaware of the knowledge of the treatment methods for this disease could curb the growth of the global cyanotic heart disease market over a forecast period.

• High Cost

The huge expenditure of the treatment methods surely hamper the market growth.

This global cyanotic heart disease market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global cyanotic heart disease market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Cyanotic Heart Disease Market        

Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Transition of healthcare infrastructure toward managing COVID-19 has led to drug launch cancellations and delays in clinical trials.

The global cyanotic heart disease market witnessed a huge negative transition during the COVID-19 pandemic as there was a decline in patient hospitalizations, because  emergency and primary care services are available during COVID-19. This has reduced the availability of diagnostic tests and impacted the sales of devices for congenital heart disease. 

Global Cyanotic Heart Disease Market Scope

The global cyanotic heart disease market is segmented on the basis of treatment type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment Type

• Medication
• Surgery

Route of Administration

• Oral
• Parenteral
• Others

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Cyanotic Heart Disease Market Regional Analysis/Insights

The global cyanotic heart disease market is analysed and market size insights and trends are provided by treatment type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global cyanotic heart disease market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to the global leaders in research and development activities and presence of refined medical facilities.

Asia-Pacific dominates the market due to the developing healthcare facilities, large number of generic manufacturer and rise in government initiatives and specialist communities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Cyanotic Heart Disease Market Share Analysis

글로벌 청색증 심장병 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 글로벌 청색증 심장병 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 청색증 심장병 시장에서 활동하는 주요 기업은 다음과 같습니다.

• Cipla Inc(인도)
• Amneal Pharmaceutical LLC(미국)
• Bausch Health Companies Inc.(캐나다)
• 파이저 주식회사(미국)
• 히크마 제약 주식회사(영국)
• 이튼 바이오텍 주식회사(미국)
• Norvartis AG(스위스)
• Fresenius Kabi AG(독일)
• Akorn 운영 회사 LLC (미국)
• Teva Pharmaceutical Industries Ltd(이스라엘)
• 마일런 NV(미국)
• 존슨앤존슨 서비스 주식회사(미국)
• 베링거인겔하임인터내셔널(미국)

SKU-53809